Manoj Amrutkar

1.4k total citations · 1 hit paper
31 papers, 1.0k citations indexed

About

Manoj Amrutkar is a scholar working on Oncology, Epidemiology and Cancer Research. According to data from OpenAlex, Manoj Amrutkar has authored 31 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 12 papers in Epidemiology and 11 papers in Cancer Research. Recurrent topics in Manoj Amrutkar's work include Pancreatic and Hepatic Oncology Research (14 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Manoj Amrutkar is often cited by papers focused on Pancreatic and Hepatic Oncology Research (14 papers), Endoplasmic Reticulum Stress and Disease (9 papers) and Liver Disease Diagnosis and Treatment (6 papers). Manoj Amrutkar collaborates with scholars based in Norway, Sweden and United States. Manoj Amrutkar's co-authors include Ivar P. Gladhaug, Margit Mahlapuu, Emmelie Cansby, Caroline S. Verbeke, Jan Borén, Monica Aasrum, Esther Nuñez‐Durán, Marcus Ståhlman, Ulf Smith and Hanns–Ulrich Marschall and has published in prestigious journals such as Diabetes, The FASEB Journal and International Journal of Molecular Sciences.

In The Last Decade

Manoj Amrutkar

30 papers receiving 1.0k citations

Hit Papers

Pancreatic Cancer Chemore... 2017 2026 2020 2023 2017 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manoj Amrutkar Norway 18 445 421 249 218 218 31 1.0k
Yaojie Fu United States 21 678 1.5× 372 0.9× 469 1.9× 81 0.4× 436 2.0× 31 1.5k
Claudia Paternostro Italy 17 475 1.1× 237 0.6× 525 2.1× 112 0.5× 289 1.3× 23 1.3k
Italia Falcone Italy 20 900 2.0× 508 1.2× 228 0.9× 87 0.4× 362 1.7× 39 1.6k
Yan Xiang China 14 832 1.9× 239 0.6× 158 0.6× 107 0.5× 614 2.8× 31 1.4k
Shuang Shang China 15 1.0k 2.3× 357 0.8× 194 0.8× 285 1.3× 299 1.4× 23 1.6k
Hongmei Cui China 19 712 1.6× 130 0.3× 158 0.6× 93 0.4× 513 2.4× 34 1.1k
Zhongguang Luo China 17 670 1.5× 277 0.7× 215 0.9× 92 0.4× 265 1.2× 39 1.1k
Xing Deng China 12 508 1.1× 162 0.4× 326 1.3× 92 0.4× 195 0.9× 21 1.1k
Mi Ran Yun South Korea 22 622 1.4× 558 1.3× 93 0.4× 54 0.2× 268 1.2× 49 1.4k

Countries citing papers authored by Manoj Amrutkar

Since Specialization
Citations

This map shows the geographic impact of Manoj Amrutkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manoj Amrutkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manoj Amrutkar more than expected).

Fields of papers citing papers by Manoj Amrutkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manoj Amrutkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manoj Amrutkar. The network helps show where Manoj Amrutkar may publish in the future.

Co-authorship network of co-authors of Manoj Amrutkar

This figure shows the co-authorship network connecting the top 25 collaborators of Manoj Amrutkar. A scholar is included among the top collaborators of Manoj Amrutkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manoj Amrutkar. Manoj Amrutkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cansby, Emmelie, Jingjing Zhang, Sheri Booten, et al.. (2025). Inhibition of GCKIII kinases STK25 and MST3 mitigates organ lipotoxicity and enhances metabolic resilience under nutritional stress. BMC Medicine. 23(1). 518–518.
2.
Sharma, Animesh, Lars Hagen, Linh Hoang, et al.. (2025). Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma. Scientific Data. 12(1). 266–266. 2 indexed citations
3.
Amrutkar, Manoj, Cristina P. R. Xavier, A. Kocijančič, et al.. (2024). Unravelling the complexities of resistance mechanism in pancreatic cancer: Insights from in vitro and ex-vivo model systems. Seminars in Cancer Biology. 106-107. 217–233. 8 indexed citations
4.
Amrutkar, Manoj, Knut Jørgen Labori, Lars Eide, et al.. (2024). Global metabolomic profiling of tumor tissue and paired serum samples to identify biomarkers for response to neoadjuvant FOLFIRINOX treatment of human pancreatic cancer. Molecular Oncology. 19(2). 391–411. 1 indexed citations
5.
Hou, Wei, et al.. (2024). Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice. International Journal of Molecular Sciences. 25(4). 2446–2446. 4 indexed citations
6.
Amrutkar, Manoj, et al.. (2023). Pancreatic stellate cell-induced gemcitabine resistance in pancreatic cancer is associated with LDHA- and MCT4-mediated enhanced glycolysis. Cancer Cell International. 23(1). 9–9. 21 indexed citations
7.
Sántha, Petra, Daniela Lenggenhager, Kristin Tøndel, et al.. (2021). Morphological Heterogeneity in Pancreatic Cancer Reflects Structural and Functional Divergence. Cancers. 13(4). 895–895. 20 indexed citations
8.
Kurhe, Yeshwant, Sima Kumari, Emmelie Cansby, et al.. (2021). Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease. The FASEB Journal. 35(5). e21567–e21567. 22 indexed citations
9.
Amrutkar, Manoj & Ivar P. Gladhaug. (2021). Stellate Cells Aid Growth-Permissive Metabolic Reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer. Cancers. 13(4). 601–601. 15 indexed citations
10.
Lenggenhager, Daniela, Manoj Amrutkar, Petra Sántha, et al.. (2019). Commonly Used Pancreatic Stellate Cell Cultures Differ Phenotypically and in Their Interactions with Pancreatic Cancer Cells. Cells. 8(1). 23–23. 27 indexed citations
11.
Amrutkar, Manoj, Monica Aasrum, Caroline S. Verbeke, & Ivar P. Gladhaug. (2019). Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. BMC Cancer. 19(1). 596–596. 86 indexed citations
13.
Amrutkar, Manoj, Daniela Lenggenhager, Caroline S. Verbeke, & Ivar P. Gladhaug. (2018). Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic adenocarcinoma. Pancreatology. 18(4). S155–S155. 1 indexed citations
14.
Cansby, Emmelie, Esther Nuñez‐Durán, Manoj Amrutkar, et al.. (2018). Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease. Cellular and Molecular Gastroenterology and Hepatology. 7(3). 597–618. 37 indexed citations
15.
Amrutkar, Manoj & Ivar P. Gladhaug. (2017). Pancreatic Cancer Chemoresistance to Gemcitabine. Cancers. 9(11). 157–157. 359 indexed citations breakdown →
16.
Nuñez‐Durán, Esther, Emmelie Cansby, Manoj Amrutkar, et al.. (2016). Overexpression of protein kinase STK25 in mice exacerbates ectopic lipid accumulation, mitochondrial dysfunction and insulin resistance in skeletal muscle. Diabetologia. 60(3). 553–567. 35 indexed citations
17.
Amrutkar, Manoj, Emmelie Cansby, Esther Nuñez‐Durán, et al.. (2015). Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. The FASEB Journal. 29(4). 1564–1576. 65 indexed citations
18.
Amrutkar, Manoj, Matthias Kern, Esther Nuñez‐Durán, et al.. (2015). Protein kinase STK25 controls lipid partitioning in hepatocytes and correlates with liver fat content in humans. Diabetologia. 59(2). 341–353. 43 indexed citations
19.
Cansby, Emmelie, et al.. (2014). Partial hepatic resistance to IL-6-induced inflammation develops in type 2 diabetic mice, while the anti-inflammatory effect of AMPK is maintained. Molecular and Cellular Endocrinology. 393(1-2). 143–151. 17 indexed citations
20.
Nerstedt, Annika, Emmelie Cansby, Manoj Amrutkar, Ulf Smith, & Margit Mahlapuu. (2013). Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes. Molecular and Cellular Endocrinology. 375(1-2). 68–78. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026